Kolon TissueGene Correction Disclosure: Minimal Reduction in Damage Claim, Negligible Impact on Shareholder Value
This correction disclosure confirms that two additional plaintiffs withdrew from the damage lawsuit as of July 9, 2026, reducing the total claim amount by approximately 104 million KRW to 29.8 billion KRW.
The reduction is negligible relative to the company's market cap of 7.39 trillion KRW, representing only 0.0014%, and the claim-to-equity ratio decreased marginally from 13.47% to 13.42%.
The lawsuit, originally filed in August 2019, remains ongoing; the company is defending through legal representatives and this amendment is a routine procedural update.
[AI Summary]The minimal claim reduction has no material impact on shareholder value or financial health. While the long-term litigation risk persists, the financial shock is limited, and investors should continue monitoring legal developments.
KOSDAQ Filing Information
[Correction of Description] Filing of Lawsuits, etc. and Application (Claims of Specified Amount or More)